Brabant Pharma brabantpharma.com


Public lists: Pharma Startups (4733)

Brabant Pharma is a single purpose company developing an oral treatment ("Brabafen") suitable for use in children with Dravet Syndrome (otherwise known as severe myoclonic epilepsy of infancy). Brabafen is low-dose fenfluramine currently under evaluation for the reduction of seizures in Dravet syndrome patients. Fenfluramine was originally developed and approved as an anoretic agent for the treatment of obesity. Although fenfluramine was withdrawn from the market in 1997 due to risk in the treat...Show all

Brabant Pharma is a single purpose company developing an oral treatment ("Brabafen") suitable for use in children with Dravet Syndrome (otherwise known as severe myoclonic epilepsy of infancy). Brabafen is low-dose fenfluramine currently under evalua...Show all

Company (Acquired)

Phone:

Fax:

74 Gartside Street

Manchester, M3 3EL
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Brabant Pharma $0M Oct 27, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Brabant Pharma Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Control system for control of distribution of medication Sep 28, 2015 Application